What does NovaBridge Biosciences do?

NovaBridge Biosciences is a public company in the Pharmaceutical Preparations industry, incorporated in E9. It is registered with the SEC under CIK 0001778016 and trades on NASDAQ under the ticker NBP.

How many SEC filings has NovaBridge Biosciences made?

NovaBridge Biosciences has filed 287 documents with the SEC since 2019. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

NovaBridge Biosciences

NBP NASDAQ CIK: 0001778016 Pharmaceutical Preparations Inc. in E9

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 287 filings →

Form	Description	Date
3	3	Mar 24, 2026
3	3	Mar 19, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for NovaBridge Biosciences. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001778016
Ticker: NBP
Exchange: NASDAQ
Incorporated: E9
First Filing: 2019
Total Filings: 287

Pharmaceutical Preparations rankings →